Literature DB >> 30238434

Clinically Relevant Prognostic Parameters in Differentiated Thyroid Carcinoma.

Tyler Janovitz1, Justine A Barletta2.   

Abstract

Although differentiated thyroid carcinomas typically pursue an indolent clinical course, it is important to identify the subset of tumors that are most likely to behave aggressively so that patients with these tumors are counseled and treated appropriately. Extent of disease is fundamental to the prognostication for differentiated thyroid carcinoma; however, there are additional histologic features of the tumor separate from extent of disease that have been shown to affect clinical course. This review will start with a discussion of aggressive variants of papillary thyroid carcinoma, move to the prognostic significance of vascular invasion in follicular thyroid carcinoma, and finish with a discussion of Hürthle cell carcinoma, with an emphasis on why it is not considered a subtype of follicular thyroid carcinoma in the 2017 WHO Classification of Tumors of Endocrine Organs.

Entities:  

Keywords:  Hobnail variant; Hürthle cell carcinoma; Risk stratification; Tall cell variant; Thyroid carcinoma

Mesh:

Year:  2018        PMID: 30238434     DOI: 10.1007/s12022-018-9548-1

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   3.943


  64 in total

1.  Genomic dissection of Hurthle cell carcinoma reveals a unique class of thyroid malignancy.

Authors:  Ian Ganly; Julio Ricarte Filho; Stephanie Eng; Ronald Ghossein; Luc G T Morris; Yupu Liang; Nicholas Socci; Kasthuri Kannan; Qianxing Mo; James A Fagin; Timothy A Chan
Journal:  J Clin Endocrinol Metab       Date:  2013-03-29       Impact factor: 5.958

2.  Hurthle cell carcinoma: a population-level analysis of 3311 patients.

Authors:  Paolo Goffredo; Sanziana A Roman; Julie A Sosa
Journal:  Cancer       Date:  2012-08-14       Impact factor: 6.860

3.  Integrated genomic characterization of papillary thyroid carcinoma.

Authors: 
Journal:  Cell       Date:  2014-10-23       Impact factor: 41.582

4.  The variable presentations of anaplastic spindle cell squamous carcinoma associated with tall cell variant of papillary thyroid carcinoma.

Authors:  Pallavi P Gopal; Kathleen T Montone; Zubair Baloch; Madalina Tuluc; Virginia LiVolsi
Journal:  Thyroid       Date:  2011-02-10       Impact factor: 6.568

5.  Papillary thyroid carcinoma with hobnail features: histopathologic criteria to predict aggressive behavior.

Authors:  Sofia Asioli; Lori A Erickson; Alberto Righi; Ricardo V Lloyd
Journal:  Hum Pathol       Date:  2012-10-01       Impact factor: 3.466

6.  Columnar-cell carcinoma of the thyroid. A report of two cases of an aggressive variant of thyroid carcinoma.

Authors:  H L Evans
Journal:  Am J Clin Pathol       Date:  1986-01       Impact factor: 2.493

7.  Impact of therapy for differentiated carcinoma of the thyroid: an analysis of 706 cases.

Authors:  N A Samaan; Y K Maheshwari; S Nader; C S Hill; P N Schultz; T P Haynie; R C Hickey; R L Clark; H Goepfert; M L Ibanez; C E Litton
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

8.  Tall cell variant of papillary thyroid carcinoma without extrathyroid extension: biologic behavior and clinical implications.

Authors:  Ronald A Ghossein; Rebecca Leboeuf; Kepal N Patel; Michael Rivera; Nora Katabi; Diane L Carlson; Giovanni Tallini; Ashok Shaha; Buvanesh Singh; R Michael Tuttle
Journal:  Thyroid       Date:  2007-07       Impact factor: 6.568

9.  Follicular thyroid carcinoma: histology and prognosis.

Authors:  Alessandra D'Avanzo; Patrick Treseler; Philip H G Ituarte; Mariwil Wong; Leanne Streja; Francis S Greenspan; Allan E Siperstein; Quan-Yang Duh; Orlo H Clark
Journal:  Cancer       Date:  2004-03-15       Impact factor: 6.860

10.  Hobnail variant of papillary thyroid carcinoma: molecular profiling and comparison to classical papillary thyroid carcinoma, poorly differentiated thyroid carcinoma and anaplastic thyroid carcinoma.

Authors:  Lianghong Teng; Wanglong Deng; Junliang Lu; Jing Zhang; Xinyu Ren; Huanli Duan; Shannon Chuai; Feidie Duan; Wei Gao; Tao Lu; Huanwen Wu; Zhiyong Liang
Journal:  Oncotarget       Date:  2017-03-28
View more
  8 in total

1.  Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy.

Authors:  Vera Wenter; Annamirl Jellinek; Marcus Unterrainer; Freba Ahmaddy; Sebastian Lehner; Nathalie Lisa Albert; Peter Bartenstein; Thomas Knösel; Christine Spitzweg; Harun Ilhan; Andrei Todica
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-08-13       Impact factor: 9.236

2.  An Evaluation of CD61 Immunohistochemistry in Identification of Vascular Invasion in Follicular Thyroid Neoplasms.

Authors:  Vincent Cracolici; Megan Parilla; Kammi J Henriksen; Nicole A Cipriani
Journal:  Head Neck Pathol       Date:  2019-06-19

3.  Late-onset distant metastases confer poor prognosis in patients with well-differentiated thyroid cancer.

Authors:  Chan Kwon Jung; Sohee Lee; Ja Seong Bae; Dong-Jun Lim
Journal:  Gland Surg       Date:  2020-10

4.  First ever case report of co-occurrence of hobnail variant of papillary thyroid carcinoma and intrathyroid parathyroid adenoma in the same thyroid lobe.

Authors:  Omer Al-Yahri; Abdelrahman Abdelaal; Walid El Ansari; Hanan Farghaly; Khaled Murshed; Mahmoud A Zirie; Mohamed S Al Hassan
Journal:  Int J Surg Case Rep       Date:  2020-05-05

5.  Clinical impact of follicular oncocytic (Hürthle cell) carcinoma in comparison with corresponding classical follicular thyroid carcinoma.

Authors:  Vera Wenter; Nathalie L Albert; Marcus Unterrainer; Freba Ahmaddy; Harun Ilhan; Annamirl Jellinek; Thomas Knösel; Peter Bartenstein; Christine Spitzweg; Sebastian Lehner; Andrei Todica
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-07-18       Impact factor: 9.236

Review 6.  Combinatorial Therapies in Thyroid Cancer: An Overview of Preclinical and Clinical Progresses.

Authors:  Gheysen Laetitia; Saussez Sven; Journe Fabrice
Journal:  Cells       Date:  2020-03-30       Impact factor: 6.600

7.  Upregulation of FTX expression is associated with a poor prognosis and contributes to the progression of thyroid cancer.

Authors:  Ping Wang; Yongming Zhang; Wenping Wang; Huimin Jiang
Journal:  Oncol Lett       Date:  2021-07-18       Impact factor: 2.967

8.  Multimodality MRI-based radiomics for aggressiveness prediction in papillary thyroid cancer.

Authors:  Zedong Dai; Ran Wei; Hao Wang; Wenjuan Hu; Xilin Sun; Jie Zhu; Hong Li; Yaqiong Ge; Bin Song
Journal:  BMC Med Imaging       Date:  2022-03-24       Impact factor: 1.930

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.